Log in
Enquire now
‌

US Patent 9469849 Methods and systems for purifying non-complexed botulinum neurotoxin

Patent 9469849 was granted and assigned to Revance Therapeutics, Inc. on October, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Revance Therapeutics, Inc.
0
Current Assignee
‌
Revance Therapeutics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
94698490
Patent Inventor Names
Curtis L. Ruegg0
Date of Patent
October 18, 2016
0
Patent Application Number
147962350
Date Filed
July 10, 2015
0
Patent Citations Received
‌
US Patent 11911449 Albumin-free botulinum toxin formulations
0
Patent Primary Examiner
‌
Albert Navarro
0
Patent abstract

Methods and systems for chromatographically purifying a botulinum neurotoxin are provided. These methods and systems allow for efficient purification of a non-complexed form of the botulinum neurotoxin in high purity and yield that can be used as an active ingredient in pharmaceutical preparations.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9469849 Methods and systems for purifying non-complexed botulinum neurotoxin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.